Piramal Pharma Solutions announces the unveiling of a new state-of-the-art “Payload-Linker Suite” at its facility in Riverview, Michigan. The company says the Riverview site provides services for pharmaceutical active ingredients (APIs) and for high potency APIs (HPAPIs). According to the announcement, the new suite offers specialized solutions related to drug payload-linking, supporting development and manufacturing work associated with these highly targeted substances. The release describes the upgrade as a modern capability addition within the company’s existing manufacturing and processing operations in the region. Both sources present the unveiling as a step to expand or enhance Piramal’s capabilities for payload-linker work, while emphasizing that the Riverview facility is built to handle both APIs and HPAPIs. No additional details on commissioning timelines, customers, capacity increases, or financial terms are provided in the available excerpts.